Dr. Catherine Weber Ballew, O.D. Optometrist Medicare: Not Enrolled in Medicare Practice Location: 12564 Chapel Rd, Lorena, TX 76655 Phone: 254-666-7949 |
News Archive
Scientists in Switzerland are reporting results of one of the first studies on the release of silver nanoparticles from laundering those anti-odor, anti-bacterial socks now on the market. Their findings, scheduled for the Nov. 1 issue of ACS' journal Environmental Science & Technology, may suggest ways that manufacturers and consumers can minimize the release of these particles to the environment, where they could harm fish and other wildlife.
UTILITY therapeutics Ltd, a pharmaceutical company focused on developing and commercializing antibiotics in the US, today announces that the US Food and Drug Administration has approved the Investigational New Drug applications for mecillinam and pivmecillinam.
Cardioxyl Pharmaceuticals, Inc., a clinical-stage pharmaceutical company developing novel therapeutic agents for the treatment of cardiovascular disease, today announced that it has achieved positive safety and tolerability results in the first clinical study of its lead drug candidate, CXL-1020, for the treatment of patients with acute decompensated heart failure. Each year in the United States, more than one million patients are hospitalized with acute heart failure.
In a study of community-dwelling Medicare beneficiaries aged 65 and older who were asked about sleep disturbances, 56% were estimated to be at high risk of obstructive sleep apnea, but only 8% of the high-risk individuals had been tested for it. Of those tested, 94% were diagnosed with obstructive sleep apnea.
Accelerate Brain Cancer Cure and Exosome Diagnostics are collaborating with leading academic medical centers to accelerate clinical validation of Exosome's blood and cerebrospinal fluid-based molecular diagnostics technology in brain cancer.
› Verified 9 days ago